Published in Br J Cancer on August 28, 2012
Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance. J Exp Clin Cancer Res (2013) 1.82
Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer. Proc Natl Acad Sci U S A (2013) 1.32
Molecular characterization of patient-derived human pancreatic tumor xenograft models for preclinical and translational development of cancer therapeutics. Neoplasia (2013) 1.17
Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA. Am J Cancer Res (2013) 1.16
Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer. Adv Drug Deliv Rev (2014) 1.00
MicroRNA let-7 downregulates STAT3 phosphorylation in pancreatic cancer cells by increasing SOCS3 expression. Cancer Lett (2014) 0.94
Clinical advances in molecular biomarkers for cancer diagnosis and therapy. Int J Mol Sci (2013) 0.92
MicroRNA-486-3p regulates γ-globin expression in human erythroid cells by directly modulating BCL11A. PLoS One (2013) 0.92
Contribution of microRNAs in understanding the pancreatic tumor microenvironment involving cancer associated stellate and fibroblast cells. Am J Cancer Res (2015) 0.91
MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers. Curr Pharm Des (2014) 0.90
The mystery of let-7d - a small RNA with great power. Contemp Oncol (Pozn) (2014) 0.89
Deregulation of miR-146a expression in a mouse model of pancreatic cancer affecting EGFR signaling. Cancer Lett (2014) 0.88
MicroRNA in pancreatic ductal adenocarcinoma and its precursor lesions. World J Gastrointest Oncol (2016) 0.87
MiR-371-5p facilitates pancreatic cancer cell proliferation and decreases patient survival. PLoS One (2014) 0.85
Integrated microRNA and mRNA transcriptome sequencing reveals the potential roles of miRNAs in stage I endometrioid endometrial carcinoma. PLoS One (2014) 0.85
Epithelial and stromal microRNA signatures of columnar cell hyperplasia linking Let-7c to precancerous and cancerous breast cancer cell proliferation. PLoS One (2014) 0.85
Circulating microRNAs and Outcome in Patients with Acute Heart Failure. PLoS One (2015) 0.83
MicroRNAs in Pancreatic Cancer: Involvement in Carcinogenesis and Potential Use for Diagnosis and Prognosis. Gastroenterol Res Pract (2015) 0.82
Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity. J Cancer Sci Ther (2015) 0.82
Dicer regulates differentiation and viability during mouse pancreatic cancer initiation. PLoS One (2014) 0.82
Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer. Oncotarget (2016) 0.82
Towards a clinical use of miRNAs in pancreatic cancer biopsies. Expert Rev Mol Diagn (2013) 0.81
MicroRNA in pancreatic cancer. J Hum Genet (2016) 0.80
Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study. Oncotarget (2016) 0.80
Let-7 Sensitizes KRAS Mutant Tumor Cells to Chemotherapy. PLoS One (2015) 0.78
Differential Expression of MicroRNAs in Tissues and Plasma Co-exists as a Biomarker for Pancreatic Cancer. J Cancer Sci Ther (2016) 0.78
Significance of microRNA-based biomarkers for pancreatic cancer. Ann Transl Med (2015) 0.77
miRNAs As Diagnostic and Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: A Review. Biomark Insights (2015) 0.76
MicroRNA-486-5p enhances hepatocellular carcinoma tumor suppression through repression of IGF-1R and its downstream mTOR, STAT3 and c-Myc. Oncol Lett (2016) 0.75
Pancreatic Cancer, A Mis-interpreter of the Epigenetic Language. Yale J Biol Med (2016) 0.75
Comparative Analysis of Differentially Expressed miRNAs and their Downstream mRNAs in Ovarian Cancer and its Associated Endometriosis. J Cancer Sci Ther (2016) 0.75
ANK1 Methylation regulates expression of MicroRNA-486-5p and discriminates lung tumors by histology and smoking status. Cancer Lett (2017) 0.75
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res (2004) 18.86
A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep (2008) 10.71
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol (2009) 8.63
Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol (2007) 4.40
Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res (2009) 4.24
A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer (2010) 2.84
Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. Cancer Res (2010) 2.50
Evaluation and validation of total RNA extraction methods for microRNA expression analyses in formalin-fixed, paraffin-embedded tissues. J Mol Diagn (2008) 2.50
Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance. Drug Resist Updat (2010) 1.98
Stable expression of miR-200c alone is sufficient to regulate TCF8 (ZEB1) and restore E-cadherin expression. Cell Cycle (2009) 1.97
Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells. J Cell Biochem (2011) 1.94
Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues. Clin Chem (2008) 1.87
Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras. Int J Radiat Oncol Biol Phys (2010) 1.85
Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer. PLoS One (2011) 1.82
Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer. Am J Transl Res (2010) 1.74
MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation. Mol Cancer (2010) 1.66
HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells. Am J Pathol (2009) 1.65
Implication of microRNAs in drug resistance for designing novel cancer therapy. Drug Resist Updat (2010) 1.61
let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. Hum Gene Ther (2009) 1.58
Accurate molecular characterization of formalin-fixed, paraffin-embedded tissues by microRNA expression profiling. J Mol Diagn (2008) 1.52
Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells. Cancer Res (2011) 1.33
Collagen regulation of let-7 in pancreatic cancer involves TGF-β1-mediated membrane type 1-matrix metalloproteinase expression. Oncogene (2010) 1.15
Accurate discrimination of pancreatic ductal adenocarcinoma and chronic pancreatitis using multimarker expression data and samples obtained by minimally invasive fine needle aspiration. Int J Cancer (2007) 1.12
Optimization and analysis of a quantitative real-time PCR-based technique to determine microRNA expression in formalin-fixed paraffin-embedded samples. BMC Biotechnol (2010) 0.97
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of solid pancreatic masses: the impact on patient-management strategy. Aliment Pharmacol Ther (2009) 0.96
Gene expression signature of advanced pancreatic ductal adenocarcinoma using low density array on endoscopic ultrasound-guided fine needle aspiration samples. Pancreatology (2011) 0.89
Network modeling of CDF treated pancreatic cancer cells reveals a novel c-myc-p73 dependent apoptotic mechanism. Am J Transl Res (2011) 0.82
Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest (1995) 3.69
Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease). J Med Genet (2005) 2.92
Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis (1992) 2.64
The histology of solitary renal allografts at 1 and 5 years after transplantation. Am J Transplant (2010) 2.40
Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect (2008) 2.30
PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR. EMBO J (1993) 2.29
Fc gamma RIII mediates neutrophil recruitment to immune complexes. a mechanism for neutrophil accumulation in immune-mediated inflammation. Immunity (2001) 2.23
The contributions of emissions and spatial microenvironments to exposure to indoor air pollution from biomass combustion in Kenya. Environ Health Perspect (2000) 2.18
Receptors for human alpha and beta interferon but not for gamma interferon are specified by human chromosome 21. Proc Natl Acad Sci U S A (1984) 1.86
Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene (2001) 1.71
Retroperitoneal ganglioneuroma: report of a case diagnosed by fine-needle aspiration cytology, with review of the literature. Diagn Cytopathol (1999) 1.52
Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene (1999) 1.50
Simultaneous respiratory tract colonization by multiple strains of nontypeable haemophilus influenzae in chronic obstructive pulmonary disease: implications for antibiotic therapy. J Infect Dis (1999) 1.49
Renal vascular sclerosis is associated with inherited thrombophilias. Kidney Int (2006) 1.48
Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev (2001) 1.43
The role of bacteria in exacerbations of COPD. A constructive view. Chest (2000) 1.42
Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant (2007) 1.40
Transplant glomerulopathy. Am J Transplant (2008) 1.29
Genistein inhibits NF-kappa B activation in prostate cancer cells. Nutr Cancer (1999) 1.26
Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int J Cancer (1994) 1.22
[Relation between asbestosis and the length of fibers]. Naturwissenschaften (1970) 1.22
Genistein-induced upregulation of p21WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells. Nutr Cancer (1998) 1.22
Magnetic resonance imaging to measure therapeutic response using an orthotopic model of human pancreatic cancer. Pancreas (2000) 1.20
Outer membrane protein CD of Branhamella catarrhalis: sequence conservation in strains recovered from the human respiratory tract. Microb Pathog (1995) 1.19
p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610. J Natl Cancer Inst (1997) 1.19
Aneurysmal bone cysts of the spine. Report of 17 cases. J Neurosurg (1985) 1.18
Receptors for human gamma interferon: binding and crosslinking of 125I-labeled recombinant human gamma interferon to receptors on WISH cells. Proc Natl Acad Sci U S A (1984) 1.18
Interferon receptors. Cross-linking of human leukocyte interferon alpha-2 to its receptor on human cells. J Biol Chem (1982) 1.17
Soy isoflavone supplementation in healthy men prevents NF-kappa B activation by TNF-alpha in blood lymphocytes. Free Radic Biol Med (2001) 1.13
bcl-2 suppresses expression of p21WAF1/CIP1 in breast epithelial cells. Cancer Res (1995) 1.13
Allograft in the treatment of benign cystic lesions of bone. Arch Orthop Trauma Surg (1993) 1.12
Fluconazole and itraconazole susceptibility of clinical isolates of Cryptococcus neoformans at a tertiary care centre in India: a need for care. J Antimicrob Chemother (2003) 1.12
A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies. Int J Radiat Oncol Biol Phys (2002) 1.11
Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agents. Pancreas (1998) 1.11
Zinc activates NF-kappaB in HUT-78 cells. J Lab Clin Med (2001) 1.10
Developments in the systemic therapy of pancreatic cancer. Cancer Invest (2003) 1.08
Eight-year study of allergic bronchopulmonary aspergillosis in an Indian teaching hospital. Mycoses (2002) 1.08
A rapid method for determination of acetylation phenotype using dapsone. Br J Clin Pharmacol (1984) 1.07
Mixed epithelial and stromal tumor of the kidney lacks the genetic alterations of cellular congenital mesoblastic nephroma. Hum Pathol (2001) 1.05
Rosette-like structures in a lymph node aspirate: pitfall in the diagnosis of neuroblastoma. Cytopathology (1997) 1.05
Galectin-3 and L1 retrotransposons in human breast carcinomas. Breast Cancer Res Treat (1998) 1.03
Klingsor syndrome: a case report. Indian J Psychiatry (2001) 1.02
Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line. Clin Cancer Res (2000) 1.01
Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a non-small-cell lung cancer cell line. Nutr Cancer (1998) 1.01
A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers. Ann Oncol (2010) 1.01
Phase II study of gemcitabine, cisplatin, and infusional fluorouracil in advanced pancreatic cancer. J Clin Oncol (2003) 1.00
MI-219-zinc combination: a new paradigm in MDM2 inhibitor-based therapy. Oncogene (2010) 1.00
Regulatory interactions of alphabeta and gammadelta T cells in glomerulonephritis. Kidney Int (2000) 1.00
Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma. Int J Pancreatol (1997) 1.00
Genistein potentiates the radiation effect on prostate carcinoma cells. Clin Cancer Res (2001) 0.99
Prevalence of Japanese encephalitis and West Nile viral infections in pig population in and around Chandigarh. J Commun Dis (1999) 0.99
Analysis of antigenic structure and human immune response to outer membrane protein CD of Moraxella catarrhalis. Infect Immun (1999) 0.99
Measuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diary. Thorax (2014) 0.98
Inhibition of pancreatic tumor cell growth in culture by p21WAF1 recombinant adenovirus. Pancreas (1998) 0.97
Treatment of chronic rhinosinusitis and its effects on asthma. Eur Respir J (2006) 0.96
Accommodative spasm with bilateral vision loss due to untreated intermittent exotropia in an adult. Nepal J Ophthalmol (2012) 0.96
Antigenic characterization and analysis of the human immune response to outer membrane protein E of Branhamella catarrhalis. Infect Immun (1997) 0.96
An orthotopic model of human pancreatic cancer in severe combined immunodeficient mice: potential application for preclinical studies. Clin Cancer Res (1998) 0.96
Inhibition of tumor cell growth by p21WAF1 adenoviral gene transfer in lung cancer. Cancer Gene Ther (1998) 0.95
Aneurysmal bone cyst of the skull. Can J Neurol Sci (1984) 0.95
Human immune response to nontypeable Haemophilus influenzae in chronic bronchitis. J Infect Dis (1997) 0.95
Induction of apoptosis and inhibition of c-erbB-2 in MDA-MB-435 cells by genistein. Int J Oncol (1999) 0.95
Bone disease in testicular and extragonadal germ cell tumours. Br J Cancer (1988) 0.95
p53-independent apoptosis induced by genistein in lung cancer cells. Nutr Cancer (1999) 0.95
A phase II study of carboplatin and paclitaxel in esophageal cancer. Ann Oncol (2004) 0.95
Clonal analysis of gliomas. Hum Pathol (1997) 0.93
The pathology and clinical features of early recurrent membranous glomerulonephritis. Am J Transplant (2012) 0.93
Clinicopathologic analysis of amphiregulin and heregulin immunostaining in breast neoplasia. Breast Cancer Res Treat (1997) 0.93
Prolapse of semilunar cusps as causes of aortic insufficiency. Circulation (1971) 0.93
Translocation of Bax to mitochondria induces apoptotic cell death in indole-3-carbinol (I3C) treated breast cancer cells. Oncogene (2000) 0.93
Production of 13-hydroxyoctadecadienoic acid (13-HODE) by prostate tumors and cell lines. Biochem Biophys Res Commun (1997) 0.92
Expression of microRNAs: potential molecular link between obesity, diabetes and cancer. Obes Rev (2011) 0.92
Rapid detection of rifampicin, isoniazid and streptomycin resistance in Mycobacterium tuberculosis clinical isolates by high-resolution melting curve analysis. J Appl Microbiol (2012) 0.90
Genistein-induced cell cycle arrest and apoptosis in a head and neck squamous cell carcinoma cell line. Nutr Cancer (1999) 0.90
Cellular interactions in the hormonal induction of alpha 2u-globulin in rat liver. J Endocrinol (1986) 0.90
An open study to assess the safety, tolerance and pharmacokinetics of an intravenous infusion of granisetron given at 3 mg over 30 s in patients receiving chemotherapy for malignant disease. Cancer Chemother Pharmacol (1995) 0.89
Comparisons of several biological and physicochemical properties of human leukocyte interferons produced my human leukocytes and by E. coli. Gene (1980) 0.89
Diagnostic significance of 'benign pairs' and signet ring cells in fine needle aspirates (FNAs) of the breast. Cytopathology (1998) 0.89
Prognostic significance of p53 gene mutations in laryngeal cancer. Laryngoscope (1999) 0.89
HER-2/neu expression in pancreatic adenocarcinoma: relation to tumor differentiation and survival. Pancreas (1997) 0.88
Hepatocurative and antioxidant profile of HP-1, a polyherbal phytomedicine. Hum Exp Toxicol (2003) 0.88
Redox cycling of endogenous copper by thymoquinone leads to ROS-mediated DNA breakage and consequent cell death: putative anticancer mechanism of antioxidants. Cell Death Dis (2013) 0.88
Inpatient burden of childhood functional GI disorders in the USA: an analysis of national trends in the USA from 1997 to 2009. Neurogastroenterol Motil (2015) 0.88
Measurement of cellular proliferation in human prostate by AgNOR, PCNA, and SPF. Prostate (1993) 0.87
Differential sensitivity of normal and malignant breast epithelial cells to genistein is partly mediated by p21(WAF1). Clin Cancer Res (2001) 0.87
Screening of patients with acute febrile illness for leptospirosis using clinical criteria and serology. Natl Med J India (2006) 0.87
Inhibition of prostate specific antigen expression by genistein in prostate cancer cells. Int J Oncol (2000) 0.87
Biologic and clinical significance of basic fibroblast growth factor immunostaining in breast carcinoma. Mod Pathol (1995) 0.87
Benign pairs. A useful discriminating feature in fine needle aspirates of the breast. Acta Cytol (1997) 0.87
Entomophthoromycosis due to Basidiobolus haptosporus. Mycoses (1997) 0.87
Intra-tubular amyloidosis. Kidney Int (2007) 0.86
Herbal modulation of drug bioavailability: enhancement of rifampicin levels in plasma by herbal products and a flavonoid glycoside derived from Cuminum cyminum. Phytother Res (2007) 0.86
Histological complexities of pancreatic lesions from transgenic mouse models are consistent with biological and morphological heterogeneity of human pancreatic cancer. Histol Histopathol (2007) 0.86
Induction of apoptosis in breast cancer cells by TPA. Oncogene (1998) 0.86
Intracellular proliferation of S. aureus in osteoblasts and effects of rifampicin and gentamicin on S. aureus intracellular proliferation and survival. Eur Cell Mater (2014) 0.86
Phase II study of pyrazoloacridine in patients with advanced colorectal carcinoma. Cancer Chemother Pharmacol (1997) 0.86
Initial experience of endobronchial silicon stents from a tertiary care centre in North India. Indian J Chest Dis Allied Sci (2011) 0.86
Anti-phospholipase A₂ receptor antibodies in recurrent membranous nephropathy. Am J Transplant (2015) 0.85